1. Seo GH, Kim SW, Chung JH. Incidence & prevalence of hyperthyroidism and preference for therapeutic modalities in Korea. J Korean Thyroid Assoc 2013;6:56-63.
[CROSSREF] [PDF]
2. Yi KH, Moon JH, Kim IJ, Bom HS, Lee J, Chung WY, et al. The diagnosis and management of hyperthyroidism consensus: report of the Korean Thyroid Association. J Korean Thyroid Assoc 2013;6:1-11.
[CROSSREF] [PDF]
3. Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 2004;14:459-462.
[CROSSREF]
5. Brent GA. Clinical practice. Graves' disease. N Engl J Med 2008;358:2594-2605.
[CROSSREF]
6. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 1983;98:26-29.
[CROSSREF] [PUBMED]
7. Nakamura H, Miyauchi A, Miyawaki N, Imagawa J. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab 2013;98:4776-4783.
[CROSSREF] [PUBMED]
8. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 1990;150:621-624.
[CROSSREF] [PUBMED]
9. Song YS, Kang SM, Ahn CW, Cha BS, Chang HS, Chung WY, et al. A case of PTU (propylthiouracil)-induced agranulocytosis in Graves' disease: additional cases of antithyroid drug-induced agranulocytosis in Yonsei University Hospital last 10 years. Korean J Med 2001;60:398-403.
10. Lee SJ, Chung ES, Kim YC, Bae YK, Chang HS, Jung JW, et al. A case of necrotizing colitis and perforation in agranulocytosis secondary to methimazole therapy. Korean J Intern Med 1980;23:161-166.
11. Oh MH, Lee JK, Kim HS, Kim HM. A case of agranulocytosis and Stevens-Johnson syndrome after propylthiouracil therapy in Graves' disease. Korean J Intern Med 1990;39:700-704.
12. You KH, Son SS, Song SY, Park MS, Lee YG, Cho CG. The effect of granulocyte colony stimulating facto(G-CSF) in a patient with propylthiouracil-induced agranulocytosis. J Korean Soc Endocrinol 1993;8:347-350.
13. Lee KW, Chung YS, Kim HM, Choi SY, Song MK, Kim HS, et al. A case of methimazole induced agranulocytosis treated with granulocyte colony stimulating factor (G-CSF). J Korean Soc Endocrinol 1997;12:68-74.
14. Park SY, Chun SW, Kim YJ, Kim SJ. A case of agranulocytosis and soft tissue abscess after increasing methimazole dose in a patient with Graves disease under long-term mainternance therapy. J Korean Thyroid Assoc 2011;4:54-57.
15. Jeong GH, Kim SK, Myung DS, Chung JO, Cho DH, Chung DJ, et al. Agranulocytosis due to secondary exposure to antithyroid drugs in a relapsed Graves' disease patient. Korean J Med 2008;75:362-366.
17. Pearce SH. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf) 2004;61:589-594.
[CROSSREF] [PUBMED]
18. Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, et al. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid 2009;19:559-563.
[CROSSREF] [PUBMED]
19. Wiberg JJ, Nuttall FQ. Methimazole toxicity from high doses. Ann Intern Med 1972;77:414-416.
[CROSSREF] [PUBMED]
20. Balkin MS, Buchholtz M, Ortiz J, Green AJ. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Thyroid 1993;3:305-309.
[CROSSREF] [PUBMED]
21. Fukata S, Kuma K, Sugawara M. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 1999;9:29-31.
[CROSSREF] [PUBMED]
22. Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007;146:657-665.
[CROSSREF] [PUBMED]
23. Toth EL, Mant MJ, Shivji S, Ginsberg J. Propylthiouracil-induced agranulocytosis: an unusual presentation and a possible mechanism. Am J Med 1988;85:725-727.
[CROSSREF] [PUBMED]
24. Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH. Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol 1986;64:363-373.
[CROSSREF] [PUBMED]
25. Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet 2012;379:1155-1166.
[CROSSREF] [PUBMED]
26. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21:593-646.
[CROSSREF] [PUBMED]
27. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. BMJ 1996;313:539-544.
[CROSSREF] [PUBMED] [PMC]